Abstract
Objective:
To assess the effectiveness of enriched intervention (EI) on symptomatic and functional outcomes, compared with standard care (SC).
Method:
Studies were retrieved from search engines and, using a metaanalytic approach, we compared EI trials with SC trials. Eleven EI sample trials (1053 patients) and 6 SC sample trials (500 patients), totalling data from 1553 patients (69% male), were examined. We calculated the effect sizes (ESs) of both symptomatic and functional improvement over a follow-up period of about 1 year.
Results:
Significant differences between EI and SC were observed at follow-up for the improvement of both positive and negative symptoms, respectively: positive, EI = −1.54 (95%CI, −1.63 to −1.45) and SC = −1.07 (95%CI, −1.19 to −0.94) (Qbetween = 40.3, df 1, P < 0.001); negative, EI = −0.44 (95%CI, −0.53 to −0.35) and SC = −0.18 (95%CI, −0.31 to −0.05) (Qbetween = 10.6, df 1, P < 0.01). We also observed a significant difference between the EI and the SC groups for functional improvement over the follow-up period with mean EI = 1.11 (95%CI, 0.99 to 1.23) and SC = 0.63 (95%CI, 0.49 to 0.77) (Qbetween = 24.5, df 1, P < 0.001).
Conclusions:
There is now quantitative evidence across multiple studies and sites to indicate that EIs for patients with recent-onset psychosis are significantly more effective than SC for symptomatic and functional improvement over a period of about 1 year.